Exact Sciences
EXAS
#1154
Rank
โ‚ฌ16.47 B
Marketcap
86,79ย โ‚ฌ
Share price
0.00%
Change (1 day)
48.24%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): -5,08ย โ‚ฌ

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -4,56ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -4,77ย โ‚ฌ.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-5,08ย โ‚ฌ6.41%
2024-4,77ย โ‚ฌ
2022-3,03ย โ‚ฌ2.31%
2021-2,97ย โ‚ฌ-38.54%
2020-4,83ย โ‚ฌ692.96%
2019-0,61ย โ‚ฌ-50.69%
2018-1,23ย โ‚ฌ44%
2017-0,86ย โ‚ฌ-39.39%
2016-1,41ย โ‚ฌ-2.94%
2015-1,46ย โ‚ฌ37.1%
2014-1,06ย โ‚ฌ79.71%
2013-0,59ย โ‚ฌ-21.59%
2012-0,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
-3,71ย โ‚ฌ-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
0,29ย โ‚ฌ-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
0,33ย โ‚ฌ-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-43,63ย โ‚ฌ 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
3,18ย โ‚ฌ-169.66%๐Ÿ‡ซ๐Ÿ‡ท France